Dongkook Wins Patent from Japan for Leuprolin Acetate Preparation

Published: 2005-03-18 06:56:00

Updated: 2005-03-18 06:56:00

Dongkook Pharmaceutical announced that it has successfully obtained a patent from Japan for the company's proprietary preparation technology of leuprolin acetate, which is marketed under the tradename Lorelin Depot Injection,

According to the company, the preparation technology for leuprolin ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK